Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02614911 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of Phenotype and Genotype of Early Onset Enteropathies

Study acronym: IMMUNOBIOTA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv10
  2. Enrollment target: 599 to 1445
    • Primary and study completion dates: Jun 15, 2034 to Jun 15, 2054
    v9
  3. Primary and study completion dates: Jun 2029 to Jun 15, 2034
    • Start date: Jun 2014 to Jun 16, 2014
    v8
  4. Enrollment target: 346 to 599v7
  5. Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Site details revised at 1 of 12 sitesv5
  2. Site details revised at 2 of 12 sitesv4
  3. Study sites: 10 to 12v3
  4. Site details revised at 1 of 10 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study has been set up in order to characterize phenotypes and genotypes of patients with early onset enteropathies. In that goal, Investigators will collect biological samples (mainly blood) of patients suffering from early onset enteropathies and their healthy relatives.
Trial Details
NCT Number NCT02614911
Lead Sponsor Imagine Institute
Conditions
(from sponsor)		 Inflammatory Bowel Disease
Related terms Inflammatory Bowel Diseases
Enrollment 1,445 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov